39 results on '"Paylar, N"'
Search Results
2. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) IN PERIPHERAL POLYNEUROPATHY IN DIABETES MELLITUS, CHRONIC KIDNEY DISEASE AND PRIMARY HYPERTENSION
3. FIRST MEDICAL WARNING. A REAL HARAKIRI. HYPERTENSIONOLOGIST'S HYPERTENSION. SAGLIKER EFFECT. CLASSICAL MANUAL BP MEASUREMENTS MUST BE BANNED BY LEGISLATIONS AND ESH AND WHO
4. STRIKING EFFICACY OF TRANSCUTANEOUS ELECTRICAL NERVE STIMULATIONS IN PERIPHERAL POLYNEUROPATHIES IN DIABETES MELLITUS II-I, CKD IV-V AND PRIMARY HYPERTENSION
5. [PP.02.24] TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) IN PERIPHERAL POLYNEUROPATHY IN DIABETES MELLITUS, CHRONIC KIDNEY DISEASE AND PRIMARY HYPERTENSION
6. [PP.07.10] PRIMAR HYPERTENSION. EARLY NEPHROSCLEROSIS BEGINS FIRST WITHIN THE LEFT KIDNEY. ERGUN'S SIGN
7. [PP.04.32] PHOSPHORUS DEFICIENCY IN MASSRY'S PHOSPHATE DEPLETION SYNDROME CAN BE ONE OF THE CAUSE OF ACUTE LEFT HEART FAILURE
8. [PP.02.25] TREATMENTS OF RESISTANT PERIPHERIC POLYNEUROPATHIES WITH DIABETES MELLITUS, CHRONIC KIDNEY DISEASE PRIMARY HYPERTENSION. HIGH TONE ELECTRICAL MUSCLE STIMULATION-HTEMS
9. PRIMARY HYPERTENSION AND NEPHROSCLEROSIS. NEPHROSCLEROSIS BEGINS FIRST WITHIN THE LEFT KIDNEY AND THIS SIGN COULD BE CALLED AS ERGUN SIGN
10. [PP.03.25] A SINE QUA NON WARNING. PATIENTS WITH LEFT HEART FAILURE MUST BE MONITORED FOR MASSRY'S PHOSPHATE DEPLETION SYNDROME AND SUPPORTED VIA PHOSPHATE SUPPLEMENTATIONS
11. [PP.25.21] STRIKING EFFICACY OF TRANSCUTANEOUS ELECTRICAL NERVE STIMULATIONS IN PERIPHERAL POLYNEUROPATHIES IN DIABETES MELLITUS II-I,CKD IV-V AND PRIMARY HYPERTENSION
12. [PP.27.26] FIRST MEDICAL WARNING.A REAL HARAKIRI. HYPERTENSIONOLOGIST'S HYPERTENSION. SAGLIKER EFFECT. CLASSICAL MANUAL BP MEASUREMENTS MUST BE BANNED BY LEGISLATIONS AND ESH AND WHO
13. PP.11.07
14. PP.12.07
15. PP.07.11
16. A controlled study of psychiatric manifestation and EEG findings in patients with Sagliker syndrome (SS)
17. Nephrosclerozis in primary hypertension first starts in left kidney and this sign may be called Ergun sign
18. Nephrosclerosis first starts in left kidney in primary hypertension. This sign may be named Ergun sign (ES)
19. Hypertensionologist' hypertension. Multiple-salvo manual BP recordings-medical harakiri procedures must be banned by legistlations via ESH, ISH and WHO. This phenomenon may be named Sagliker Effect (SE)
20. Cephalometric findings of the patients with Sagliker syndrome: Uglifying human face appearances in CKD
21. Evaluation of hearing functions on the patients with Sagliker syndrome
22. Neurological manifestations in chronic renal failure patients with Sagliker syndrome
23. Audiological findings in patients with Sagliker syndrome (SS)
24. Sagliker effect (SE) and hypertensionologist hypertension in medical doctors and nurses. Multiple-salvo manual BP recordings which are medical harakiri procedures must be banned
25. Sagliker effect(SE) and hypertensionologist hypertension (HH) in medical doctors and nurses. Multiple-salvo manual BP recordings which are medical Harakiri procedures must be banned by legislation and via ESH, ISH and WHO
26. Sagliker effect (SE) and hypertensionologist hypertension in medical doctors and nurses. Manual BP recordings which is a Harakiri procedure must be banned
27. 867 A NEW PHENOMENON
28. 649 MANUAL BP RECORDINGS MUST BE BANNED WORLD WIDELY BY LEGISLATIONS, ERA-EDTA, ISH AND WHO COMPILATION OF REVERSE WHITE COAT EFFECT AND PHYSICAL EXERCISE. SAGLIKER EFFECT. A MILD HARAKIRI PROCEDURE
29. Hypertension
30. Mineral and bone disease - CKD 1-5
31. Bone disease in CKD 1-5
32. SAGLIKER EFFECT (SE) AND HYPERTENSIONOLOGIST HYPERTENSION IN MEDICAL DOCTORS AND NURSES. MANUAL BP RECORDINGS WHICH IS A HARAKIRI PROCEDURE MUST BE BANNED
33. Is survival enough for quality of life in Sagliker Syndrome-uglifying human face appearances in chronic kidney disease?
34. Chromosomal findings and sequence analysis of target exons of calcium-sensingreceptor (CaSR) gene in patients with Sagliker syndrome.
35. International evaluation of unrecognizably uglifying human faces in late and severe secondary hyperparathyroidism in chronic kidney disease. Sagliker syndrome. A unique catastrophic entity, cytogenetic studies for chromosomal abnormalities, calcium-sensing receptor gene and GNAS1 mutations. Striking and promising missense mutations on the GNAS1 gene exons 1, 4, 10, 4.
36. Is survival enough for quality of life in Sagliker Syndrome-uglifying human face appearances in chronic kidney disease?
37. International study on Sagliker syndrome and uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic kidney disease patients.
38. Neurologic manifestations in Sagliker syndrome: uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic renal failure patients.
39. Cephalometric evaluation of patients with Sagliker syndrome: uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic renal failure patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.